The SSTR2 expression in gastric cancer was interpreted based on the HER2 interpretation criteria outlined in the 2020 Chinese consensus on the pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms. This evidence concerns the gene ERBB2 and gastric cancer.